Automated Breast Ultrasound Systems Market to exceed $ 1930 Mn by 2025

October 22, 2019


According to the new research report available at MarketStudyReport.com under the title ‘Global (United States, European Union and China) Automated Breast Ultrasound Systems (ABUS) Market Research Report 2019-2025’, the worldwide automated breast ultrasound systems market is anticipated to surpass US $1930 million by the year 2025.
 

Automated breast ultrasound system (ABUS) is an advanced alternative to traditional supplement screening options like handheld ultrasound. The technique is reported to improve cancer detection in dense breast women by 35%. ABUS provides 3D volumetric image of breast area using ultrasound waves allowing better interpretation by enabling the physician to view breast from various angles. Growing awareness towards symptoms of breast cancer, coupled with increasing cases of disease around the globe are encouraging the adoption of ABUS, thereby fueling market growth. Extensive research & development for advanced imaging techniques and growing government advocation towards the breast cancer awareness will further drive the growth of ABUS market.
 

According to the report, automated breast ultrasound systems market was worth US $590 million in 2019 and is predicted grow with a CAGR of 16% over the forecast timeframe. Furthermore, the report provides a comprehensive insight about the production and consumption patterns, alongside the trends, drivers, challenges, threats, and opportunities impacting the market growth. Information about revenue shares, capacity graphs, value chain, sales channels, and customer spectrum is also encompassed.
 

ABUS market is studied on the basis of application spectrum, product type and regional landscape. Based on the application spectrum, the market is fragmented as diagnostic imaging centers and hospitals.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2184580/  
 

Speaking of the product type, the market is segmented as automated breast volume scanner and automated breast ultrasound systems. While considering the regional landscape, the global ABUS market is divided into four main regions which are China, United States, European Union and rest of the world including India, Southeast Asia, Japan and Korea.
 

The prominent companies operating in ABUS market include Toshiba Company, GE Healthcare, MetriTrack, Hitachi, Real Imaging, Koninklijke Philips N.V., Theraclion, Siemens, Shantou Institute of Ultrasonic Instruments, SonoCine, Nova Medical Imaging Technology Ltd., QView Medical, Supersonic Imagine, Seno Medical Instruments, CapeRay, Delphinus Medical Technologies, and Volpara Solutions.


Frequently Asked Questions (FAQ) :

Automated breast ultrasound system (ABUS) is an advanced alternative to traditional supplement screening options like handheld ultrasound. The technique is reported to improve cancer detection in dense breast women by 35%. Since ABUS provides 3D volumetric image of breast area using ultrasound waves allowing better interpretation by enabling the physician to view the breast from various angles, it is considered a highly accurate technique.
The global ABUS market is divided into four main regions which are China, United States, European Union and rest of the world including India, Southeast Asia, Japan and Korea.
The prominent companies operating in ABUS market include Toshiba Company, GE Healthcare, MetriTrack, Hitachi, Real Imaging, Koninklijke Philips N.V., Theraclion, Siemens, Shantou Institute of Ultrasonic Instruments, SonoCine, Nova Medical Imaging Technology Ltd., QView Medical, Supersonic Imagine, Seno Medical Instruments, CapeRay, Delphinus Medical Technologies, and Volpara Solutions.
Growing awareness towards symptoms of breast cancer, coupled with increasing cases of disease around the globe are encouraging the adoption of ABUS, thereby fueling market growth. Extensive research & development for advanced imaging techniques and growing government advocation towards the breast cancer awareness will further drive the growth of ABUS market. Apparently, automated breast ultrasound systems market was worth US $590 million in 2019 and is predicted grow with a CAGR of 16% over the forecast timeframe.